Cerevel Therapeutics Hldng I shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Cerevel Therapeutics Hldng I
Tip: Access up to 7 years of quarterly data
All positions including Cerevel Therapeutics Hldng I held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cerevel Therapeutics Hldng I by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $307k | 7.2k | 42.40 |
| 2023-09-30 | $134k | 6.1k | 21.83 |
| 2023-06-30 | $162k | 5.1k | 31.79 |
| 2023-03-31 | $112k | 4.6k | 24.39 |
| 2022-12-31 | $149k | 4.6k | 32.47 |
| 2022-09-30 | $115k | 4.1k | 28.21 |
| 2022-06-30 | $107k | 4.1k | 26.25 |
| 2022-03-31 | $108k | 3.1k | 35.14 |
| 2021-12-31 | $100k | 3.1k | 32.54 |
| 2021-09-30 | $91k | 3.1k | 29.61 |
| 2021-06-30 | $71k | 2.8k | 25.68 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors